The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Consensus molecular subtype (CMS) as a novel integral biomarker in colorectal cancer: A phase II trial of bintrafusp alfa in CMS4 metastatic CRC.
 
Amir Mehrvarz Sarshekeh
No Relationships to Disclose
 
Michael Lam
No Relationships to Disclose
 
Isabel R. Zorrilla
No Relationships to Disclose
 
Emma Brey Holliday
No Relationships to Disclose
 
Prajnan Das
Consulting or Advisory Role - Adlai Nortye
 
Bryan K. Kee
Stock and Other Ownership Interests - Medtronic
 
Michael J. Overman
Consulting or Advisory Role - Array BioPharma; Bristol-Myers Squibb; Gritstone Bio; MedImmune; Novartis; Promega; Roche/Genentech; Spectrum Pharmaceuticals
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Christine Megerdichian Parseghian
No Relationships to Disclose
 
John Paul Y.C. Shen
Stock and Other Ownership Interests - Tetraphase Pharma
Research Funding - IDEAYA Biosciences (Inst)
 
Alda Tam
Honoraria - Endocare; Galil Medical; Merit Medical Systems
Consulting or Advisory Role - Abbvie; Boston Scientific; Jounce Therapeutics; Siemens
Research Funding - AngioDynamics; BTG; Guerbet
Travel, Accommodations, Expenses - Guerbet
 
Edwin Roger Parra Cuentas
No Relationships to Disclose
 
Liren Zhang
No Relationships to Disclose
 
Xuemei Wang
No Relationships to Disclose
 
Dzifa Yawa Duose
No Relationships to Disclose
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Neelima Reddy
No Relationships to Disclose
 
Dipen M. Maru
No Relationships to Disclose
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Amgen; AstraZeneca/MedImmune; Bayer Health; Biocartis; Boehringer Ingelheim; Boston Biomedical; Daiichi Sankyo; EMD Serono; EMD Serono; Genentech; Holy Stone Healthcare; Ipsen; Karyopharm Therapeutics; Lilly; Merck; Natera; Navire; Novartis; Pierre Fabre; Redx Pharma; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); Lilly (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
Van K. Morris
Honoraria - Projects in Knowledge
Consulting or Advisory Role - Array Biopharma; Incyte
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); EMD Serono (Inst)